Skip to main content
. 2011 Jul 4;208(7):1501–1510. doi: 10.1084/jem.20110574

Figure 5.

Figure 5.

Impact of the mTOR inhibitor everolimus on development of diabetes. Cumulative diabetes incidence of NOD mice treated with a combination of the natural insulin epitope or the mimetope plus everolimus (3 mg/kg i.p. for 14 d) or everolimus alone. n = 12 from three independent experiments. *, P < 0.05 versus insulin B:9-23 + everolimus.